TR200002921T2 - Yarı-Sentetik ekteinasidinler - Google Patents

Yarı-Sentetik ekteinasidinler

Info

Publication number
TR200002921T2
TR200002921T2 TR2000/02921T TR200002921T TR200002921T2 TR 200002921 T2 TR200002921 T2 TR 200002921T2 TR 2000/02921 T TR2000/02921 T TR 2000/02921T TR 200002921 T TR200002921 T TR 200002921T TR 200002921 T2 TR200002921 T2 TR 200002921T2
Authority
TR
Turkey
Prior art keywords
synthetic
semi
ekteinacids
acidacid
boc
Prior art date
Application number
TR2000/02921T
Other languages
English (en)
Turkish (tr)
Inventor
Lloyd Rinehart Kenneth
J Morales Jose
Original Assignee
The Board Of Trustees Of The University Of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Trustees Of The University Of Illinois filed Critical The Board Of Trustees Of The University Of Illinois
Publication of TR200002921T2 publication Critical patent/TR200002921T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Dental Preparations (AREA)
TR2000/02921T 1998-04-06 1999-04-05 Yarı-Sentetik ekteinasidinler TR200002921T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8080298P 1998-04-06 1998-04-06

Publications (1)

Publication Number Publication Date
TR200002921T2 true TR200002921T2 (tr) 2001-02-21

Family

ID=22159716

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02921T TR200002921T2 (tr) 1998-04-06 1999-04-05 Yarı-Sentetik ekteinasidinler

Country Status (27)

Country Link
US (1) US6124293A (enExample)
EP (2) EP1067933B1 (enExample)
JP (1) JP4443043B2 (enExample)
KR (1) KR100603219B1 (enExample)
CN (1) CN1157189C (enExample)
AT (1) ATE370148T1 (enExample)
AU (1) AU758100B2 (enExample)
BG (1) BG65088B1 (enExample)
BR (1) BR9909488B1 (enExample)
CA (1) CA2327468C (enExample)
CY (1) CY1106988T1 (enExample)
CZ (1) CZ301083B6 (enExample)
DE (1) DE69936845T2 (enExample)
DK (1) DK1067933T3 (enExample)
ES (1) ES2292237T3 (enExample)
HU (1) HUP0104273A3 (enExample)
IL (2) IL138856A0 (enExample)
MX (1) MXPA00009840A (enExample)
NO (1) NO328147B1 (enExample)
NZ (1) NZ507350A (enExample)
PL (1) PL196809B1 (enExample)
PT (1) PT1067933E (enExample)
RU (1) RU2217432C2 (enExample)
SK (1) SK285669B6 (enExample)
TR (1) TR200002921T2 (enExample)
UA (1) UA59439C2 (enExample)
WO (1) WO1999051238A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985876A (en) * 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
IL139607A0 (en) * 1998-05-11 2002-02-10 Pharma Mar Sa Metabolites of ecteinascidin 743
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
MY130271A (en) * 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
EP1254140A4 (en) 2000-01-19 2003-03-12 Univ Columbia SAFRAMYCIN-ECTEINASCIDIN SERIES COMPOUNDS, USAGE AND SYNTHESIS THEREOF
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
JP2004529074A (ja) 2000-11-03 2004-09-24 プレジデント アンド フェロウズ オブ ハーバード カレッジ サフラマイシン、そのアナログ、およびその使用
WO2002036135A2 (en) * 2000-11-06 2002-05-10 Pharma Mar, S.A. Compositions for antitumour treatment containing ecteinascidin 743
GB0117402D0 (en) 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
JP2007511499A (ja) * 2003-11-13 2007-05-10 ファーマ・マール・エス・アー・ウー コンビネーション
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
JP2007511509A (ja) * 2003-11-14 2007-05-10 ファルマ・マール・ソシエダード・アノニマ Ｅｔ−７４３およびパクリタキセルの使用を含むガンの併用療法
JP2008505862A (ja) * 2004-07-09 2008-02-28 ファルマ、マール、ソシエダード、アノニマ 予後分子マーカー
WO2006035244A2 (en) * 2004-09-29 2006-04-06 Pharma Mar S.A., Sociedad Unipersonal Ecteinascidin compounds as anti -inflammatory agents
RS50822B (sr) * 2004-10-26 2010-08-31 Pharma Mar S.A., Sociedad Unipersonal Pegilovani lipozomalni doksorubicin u kombinaciji sa ekteinescidinom 743
KR101188691B1 (ko) 2004-10-29 2012-10-09 파르마 마르 에스.에이. 엑티나시딘 및 디사카라이드를 포함하는 제제
GB0522082D0 (en) 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CN100355775C (zh) * 2006-01-20 2007-12-19 南方医科大学 一种海鞘多肽及其制备方法
WO2009050303A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Prognostic molecular markers for et-743 treatment
EP2786755A3 (en) 2010-11-12 2014-10-29 Pharma Mar S.A. Combination therapy with an antitumor alkaloid
RU2738741C2 (ru) * 2016-02-04 2020-12-16 Цзянсу Хэнжуй Медицин Ко., Лтд. Инъекционная фармацевтическая композиция, включающая трабектедин, для применения вне желудочно-кишечного тракта и способ её получения
LT3615544T (lt) 2017-04-27 2023-05-10 Pharma Mar S.A. Priešnavikiniai junginiai
CA3158733A1 (en) 2019-11-21 2021-05-27 Pilar Calvo Methods of treating small cell lung cancer with lurbinectedin formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5149804A (en) * 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
TW221441B (enExample) * 1991-01-25 1994-03-01 Taiho Pharmaceutical Co Ltd
US5440055A (en) * 1993-03-12 1995-08-08 Aphios Corporation Method and apparatus for extracting taxol from source materials
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds

Also Published As

Publication number Publication date
CZ20003650A3 (en) 2001-06-13
KR20010074474A (ko) 2001-08-04
HUP0104273A2 (hu) 2002-03-28
ATE370148T1 (de) 2007-09-15
BG104902A (en) 2001-07-31
JP4443043B2 (ja) 2010-03-31
BR9909488A (pt) 2000-12-26
CN1157189C (zh) 2004-07-14
AU3471399A (en) 1999-10-25
JP2002510633A (ja) 2002-04-09
CZ301083B6 (cs) 2009-11-04
DK1067933T3 (da) 2007-12-27
SK285669B6 (sk) 2007-06-07
NO20004978L (no) 2000-12-05
IL138856A0 (en) 2001-10-31
HK1033651A1 (en) 2001-09-14
NO20004978D0 (no) 2000-10-03
EP1067933A1 (en) 2001-01-17
HUP0104273A3 (en) 2003-12-29
DE69936845T2 (de) 2008-05-08
CA2327468C (en) 2008-05-06
AU758100B2 (en) 2003-03-13
CA2327468A1 (en) 1999-10-14
RU2217432C2 (ru) 2003-11-27
PL343439A1 (en) 2001-08-13
US6124293A (en) 2000-09-26
CY1106988T1 (el) 2012-09-26
EP1876180A2 (en) 2008-01-09
DE69936845D1 (de) 2007-09-27
RU2000128058A (ru) 2004-02-20
KR100603219B1 (ko) 2006-07-20
WO1999051238A1 (en) 1999-10-14
ES2292237T3 (es) 2008-03-01
PL196809B1 (pl) 2008-02-29
EP1067933B1 (en) 2007-08-15
NO328147B1 (no) 2009-12-21
NZ507350A (en) 2003-03-28
CN1304309A (zh) 2001-07-18
MXPA00009840A (es) 2002-04-24
BR9909488B1 (pt) 2011-02-08
EP1067933A4 (en) 2002-12-18
IL138856A (en) 2007-07-24
WO1999051238A9 (en) 2000-01-27
BG65088B1 (bg) 2007-02-28
EP1876180A3 (en) 2009-12-16
PT1067933E (pt) 2007-11-15
UA59439C2 (uk) 2003-09-15
SK15012000A3 (sk) 2001-08-06

Similar Documents

Publication Publication Date Title
FI914928L (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
DE69112290D1 (de) Verspritzbare, feuerfeste Zusammensetzung.
ID23374A (id) Halogenopirimidin
TR199900239T2 (enExample)
BR9909488A (pt) Ecteinascidinas semi-sintéticas
DE3582953D1 (de) Faserhaltige, teilchenfoermige elastomerzusammensetzung.
DE69005438D1 (de) Bernsteinsäureimid-Zusammensetzungen.
DE3585294D1 (de) Molekularsiebzusammensetzungen.
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
FI931427L (fi) Ny onkofetal gen, genprodukt och anvaendningen daerav
DE3775170D1 (de) Trockenes abziehbild, dessen unerwuenschte flaechen sich selbststaendig von den bildflaechen trennen.
DE3584905D1 (de) Molekularsiebzusammensetzungen.
FI923536A7 (fi) Foerfarande foer analysering av gasprov, analyseringsanordning, dess anvaendning och en test anlaeggning med den naemnda analyseringsanordningen.
DE69016390D1 (de) Nitrierofen.
FI875703A7 (fi) Lääkelaastarikoostumuksia.
DE69020121D1 (de) Gasbetriebenes Kochfeld.
DE3576488D1 (de) Molekularsieb-zusammensetzungen.
DE69014859D1 (de) Spleissverschlüsse.
FR2707297B1 (fr) Mélange silicone autoémulsifiable.
DE69725459D1 (de) Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
EP1082126A4 (en) NEW PEPTIDES
DE69014095D1 (de) Bernsteinsäureimid-Zusammensetzungen.
FI913371A0 (fi) Foerfarande och anordning foer provtagning av en vaetska, vilken innehaoller en upploest gas.
FI905350A0 (fi) Komposition innehaollande maerkta streptokock-antikroppar,testfoerpackning och analysfoerfarande, i vilket den anvaends.
FR2720395B1 (fr) Nouveaux composés de la famille des benzohétérocycles.